Cargando…
Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications
Nonalcoholic fatty liver disease (NAFLD) represents one of the most common liver disorders and can progress into a series of liver diseases, including nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and even liver cancer. Interleukin-22 (IL-22), a member of the IL-10 family of cytokines, i...
Autores principales: | Zai, Wenjing, Chen, Wei, Liu, Hongrui, Ju, Dianwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698419/ https://www.ncbi.nlm.nih.gov/pubmed/34944732 http://dx.doi.org/10.3390/biomedicines9121912 |
Ejemplares similares
-
Molecular mechanism of alcoholic fatty liver
por: Rasineni, Karuna, et al.
Publicado: (2012) -
Tethering Interleukin-22 to Apolipoprotein A-I Ameliorates Mice from Acetaminophen-induced Liver Injury
por: Chen, Wei, et al.
Publicado: (2017) -
Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury
por: Chen, Wei, et al.
Publicado: (2020) -
Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
por: Pei, Qiying, et al.
Publicado: (2023) -
Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis
por: Abdelnabi, Mohamed N., et al.
Publicado: (2022)